Goldberg, S. B., Gettinger, S. N., Mahajan, A., Chiang, A. C., Herbst, R. S., Sznol, M., . . . Kluger, H. M. (2016). A Phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases. Lancet Oncol.
Chicago-стиль цитированияGoldberg, Sarah B., et al. "A Phase II Trial of Pembrolizumab for Patients With Melanoma or Non-small Cell Lung Cancer and Untreated Brain Metastases." Lancet Oncol 2016.
MLA-цитированиеGoldberg, Sarah B., et al. "A Phase II Trial of Pembrolizumab for Patients With Melanoma or Non-small Cell Lung Cancer and Untreated Brain Metastases." Lancet Oncol 2016.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.